689.65 million, equaled to 96.14% of the total revenue from operations. The increase in sales was THB 99.35 million which comprised of 2 main segments as follows: 1- The increase in domestic sales was THB

is the company's main trading currency) Detail of Domestic and Export Sales 2019 0202 selaS ropxE  Connxd Ewxx caSn (RKI) 474404 492424  FSxEh vxgx obpx ond fSui (AF) 96489 96492  Pauchxd Ewxx caSn

. The current rules require both the issuers as well as all affiliates that engage in the main business of a group of companies to meet the qualifications and disclose information in the Filing Form

system, especially big companies and financial institutions, inevitably disclose the impacts on climate in accordance with Task Force on Climate-related Financial Disclosures (TCFD) which has four main

Baht per share, the disposal value of Baht 115 million, and the Company was paid for the disposal of such share proportion on August 15, 2017, resulting in the change of the Company’s shareholding

selling medical equipment 108.10 63.62 Administrative expenses 99.81 104.41 Finance costs 23.47 23.13 Finance costs (net) 21.16 20.58 Proportion of cost of medical treatment / revenue of medical treatment

Thailand Tel. 66-38 480-020-1 FAX. 66-38 480-080 4.2 Investment Proportion (Shareholding Proportion) - Before Investment : : 4,961 ordinary share or 35.44 of registered capital - After Investment : 11,954

398.21 314.81 Administrative expenses 460.64 414.05 Loss from Impairment of Investment 56.89 - Finance costs 61.87 92.81 Finance costs (net) 46.22 83.33 Proportion of cost of medical treatment / revenue of

10 per share. EFORL subscribed its right of Baht 436,499,970. After the first allotment has been completed, as at 31 December 2018, the proportion of shareholding in WCIH of EFORL is 63.7% of paid up

treatment 582.81 568.86 Cost of selling medical equipment 85.44 108.10 Administrative expenses 146.98 99.81 Finance costs 15.27 23.47 Finance costs (net) 12.81 21.16 Proportion of cost of medical treatment